g., institutional differences in experimental conditions, tumor purity, etc. [59–62]) results in challenges in interpreting differences in clock function and drawing conclusions from smaller subsets of patients, particularly with algorithms like CYCLOPS [28]. The gene discussed is CLOCK; the disease is neoplasm.